Australia's most trusted
source of pharma news
Thursday, 18 June 2026
Posted 18 June 2026 AM
Novartis has lost a bid to have the trade mark of Pharmacor's generic version of Entresto removed for non use.
In a cheeky move, the Swiss pharma argued Pharmacor had not used the Valtresto trade mark for a three-year period ending 19 February 2025. It filed the application in March 2025, just before Valtresto hit the PBS.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.